A Paclitaxel-Eluting Stent for the Prevention of Coronary Restenosis | Zendy

SeungJung Park | Zendy; Won Heum Shim | Zendy; David Sai Wah Ho | Zendy; Albert E. Raizner | Zendy; SeongWook Park | Zendy; MyeongKi Hong | Zendy; Cheol Whan Lee | Zendy; Donghoon Choi | Zendy; Yangsoo Jang | Zendy; Ricky Lam | Zendy; Neil J. Weissman | Zendy; Gary S. Mintz | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

A Paclitaxel-Eluting Stent for the Prevention of Coronary Restenosis

Author(s) -

SeungJung Park,

Won Heum Shim,

David Sai Wah Ho,

Albert E. Raizner,

SeongWook Park,

MyeongKi Hong,

Cheol Whan Lee,

Donghoon Choi,

Yangsoo Jang,

Ricky Lam,

Neil J. Weissman,

Gary S. Mintz

Publication year - 2003

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa021007

Subject(s) - medicine , cilostazol , restenosis , paclitaxel , stent , intravascular ultrasound , urology , neointimal hyperplasia , cardiology , intimal hyperplasia , ticlopidine , aspirin , coronary stent , clopidogrel , surgery , chemotherapy , smooth muscle

Intimal hyperplasia and resulting restenosis limit the efficacy of coronary stenting. We studied a coronary stent coated with the antiproliferative agent paclitaxel as a means of preventing restenosis.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research